I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Our guest today is Matthew Mace.

He is redefining what leadership looks like at the cutting edge of clinical research on multiple fronts.

Founder of Study Connect Inc., where he’s on a mission to streamline scientific innovation through faster trials and smarter collaboration. He’s not just building a platform—he’s shaping a movement.

You might also know him as the host of the Study Success podcast, where he amplifies bold ideas and practical strategies driving real progress in our industry.

And now, as a newly appointed Board Director at Precision Cardiovascular, he’s bringing his deep expertise in cardiac innovation to a company creating the next generation of monitoring tech.

Previously, as Co-Founder and CSO at Acorai, Matthew led the largest hemodynamic study in heart failure history, secured FDA Breakthrough Device Designation, and raised over $10 million to bring a novel technology to market.

With over 15 years across cardiology, AI, and medtech—plus a knack for turning vision into impact—Matthew brings unmatched perspective, purpose, and drive.

He is passionate about new technologies and exploring the boundaries to continue the evolution of patient care.

His aim is to further enhance the reach of lifesaving technology into the hands of healthcare professionals for the benefit of patients.